Clinical trials are designed to push the boundaries of medical #innovation. We're enrolling patients now to advance cutting-edge #research across multiple diseases. For more information on our ongoing #clinicaltrials, visit: https://bit.ly/4bJ7HCP #ClinicalTrialsDay #CTD2024
Biohaven
生物技术研究
New Haven，CT 49,231 位关注者
A modern pharmaceutical company guided by science and inspired to change the lives of people with unmet medical needs.
关于我们
Biohaven is a uniquely different pharmaceutical company. We are an agile and resilient team of highly skilled professionals who eagerly challenge the status quo to advance novel, life-changing therapies. People are at the center of all we do. The unmet needs of patients inspire us to follow scientific innovation wherever it leads and motivates our resolve for overcoming the obstacles that stand in the way of medical progress. It is all part of the patient-first culture we proudly call the “Biohaven Way.” If you’d like to join us, please visit our Careers page: https://www.biohaven.com/careers/ For Investor news and financial information about Biohaven (NYSE: BHVN): https://ir.biohaven.com/ View our Pipeline: https://www.biohaven.com/pipeline/
- 网站
-
https://www.biohaven.com
Biohaven的外部链接
- 所属行业
- 生物技术研究
- 规模
- 201-500 人
- 总部
- New Haven，CT
- 类型
- 上市公司
- 创立
- 2022
- 领域
- Neurology、Oncology和Neuroscience
地点
-
主要
获取路线
215 Church Street
US，CT，New Haven，06510
Biohaven员工
动态
-
There is still a crucial unmet need in treatment options for rare diseases like spinocerebellar ataxia (SCA). Patients are waiting and #DaysMatter, but as a community we have the opportunity to use our voices to support disease awareness and generate urgency to change the lives of people with unmet medical needs.
-
Thank you to everyone who stopped by our booth during Epilepsy Awareness Day at Disneyland Resort! Our team had an incredible time connecting with the #epilepsy community and sharing insights into our efforts to support people living with this disorder. #ThePurplestPlaceOnEarth #EpilepsyAwarenessDayAtDisneyland
-
-
Hear from Mark Angelicola, our Senior Director of Clinical Operations on why #DaysMatter is more than just a motto to us. Our diverse #teams #collaborate to bring treatments to patients with unmet needs as efficiently as possible, combining our unique experiences to make a real impact.
-
Dr. Jeremy Schmahmann is the director of the Ataxia Center at Mass General Hospital and has witnessed firsthand the impact #SCA has on #patients and their families. Read his recent article in The Hill to learn how collaboration between clinicians, researchers, regulators, and patient advocates is paving the way for new treatments: https://brnw.ch/21wOQM9 #SCAawareness #AtaxiaAwareness #Ataxia
-
Our Chief Medical Officer, Irfan Qureshi, M.D., was recently featured in an article from Pharmaceutical Executive discussing his career, Biohaven’s pipeline and company culture. Check it out: https://brnw.ch/21wOKvQ #BeBiohaven
-
Our team had the incredible opportunity to attend the CNS Summit, where we connected with leading minds in #clinicaldevelopment, #neuroscience, and #healthcare innovation. #DaysMatter
-
-
Join us on Epilepsy Awareness Day at Disneyland Resort for the largest gathering of epilepsy physicians and patients. Stop by our booth to connect with our team, ask questions, and discover how we’re working towards better treatments and support for the #epilepsy community. Register here: https://bit.ly/3NWRC2K #ThePurplestPlaceOnEarth #EpilepsyAwarenessDayAtDisneyland #EndTheEpilepsyStigma
-
-
This #VeteransDay, we’re proud to recognize and honor some of our team members who have served our country. Thank you for your service, Rosalie Riccio and David Saunders! ???? #BeBiohaven